US Patent 7745149 Tumor markers for ovarian cancer diagnosis

Patent 7745149 was granted and assigned to National Taiwan University on June, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

National Taiwan University

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7745149

Date of Patent

June 29, 2010

Patent Application Number

12326369

Date Filed

December 2, 2008

Patent Primary Examiner

‌

Stephen L. Rawlings

Patent abstract

The present invention relates to a tumor marker for diagnosis of ovarian cancer, which is selected from the group consisting of galectin-1, cathepsin B, MHC class I antigen, heat shock protein (HSP) 27, ubiquitin carboxy-termal esterase L1, plasma retinol-binding protein (PRBP), transthyretin, SH3 binding glutamate-rich protein, tubulin-specific chaperone A, RNA binding protein regulatory subunit, γ-actin, tropomyosin and calcium/calmodulin-stimulated cyclic nucleotide phosphatase. The ovarian cancer is diagnosed effectively and efficiently based on detecting the expression levels of the tumor markers in the invention from the ovarian tissue sample of an individual to be diagnosed.